
Jana A. Hines
Examiner (ID: 3740, Phone: (571)272-0859 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1641 |
| Total Applications | 1210 |
| Issued Applications | 525 |
| Pending Applications | 181 |
| Abandoned Applications | 525 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17429650
[patent_doc_number] => 20220057359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => PORTABLE DEVICE AND SYSTEM FOR RAPID DETECTION OF A BACTERIAL CELL IN FLUID SAMPLES
[patent_app_type] => utility
[patent_app_number] => 17/453529
[patent_app_country] => US
[patent_app_date] => 2021-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 318
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17453529
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/453529 | Portable device and system for rapid detection of a bacterial cell in fluid samples | Nov 3, 2021 | Issued |
Array
(
[id] => 18830884
[patent_doc_number] => 20230399409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => ANTIBODY TARGETING INTERLEUKIN 36R, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/034985
[patent_app_country] => US
[patent_app_date] => 2021-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12662
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034985
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/034985 | ANTIBODY TARGETING INTERLEUKIN 36R, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Nov 3, 2021 | Pending |
Array
(
[id] => 17881179
[patent_doc_number] => 20220296656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA
[patent_app_type] => utility
[patent_app_number] => 17/517084
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17517084
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/517084 | TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA | Nov 1, 2021 | Pending |
Array
(
[id] => 18806979
[patent_doc_number] => 20230381312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => REDIRECTING GLUCOSE METABOLISM TO LIMIT STRESS AND IMPROVE ADOPTIVE CELL THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/034027
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034027
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/034027 | REDIRECTING GLUCOSE METABOLISM TO LIMIT STRESS AND IMPROVE ADOPTIVE CELL THERAPY | Oct 26, 2021 | Pending |
Array
(
[id] => 17414075
[patent_doc_number] => 20220048979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => TREATMENT OF STAPHYLOCOCCAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/508692
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17508692
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/508692 | Treatment of staphylococcal disorders | Oct 21, 2021 | Issued |
Array
(
[id] => 18595996
[patent_doc_number] => 20230270787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => CELL SURFACE ANTIGEN OF ACTIVATED IMMUNE CELL AND VARIOUS USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/250209
[patent_app_country] => US
[patent_app_date] => 2021-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250209
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/250209 | CELL SURFACE ANTIGEN OF ACTIVATED IMMUNE CELL AND VARIOUS USES THEREOF | Oct 20, 2021 | Pending |
Array
(
[id] => 18786472
[patent_doc_number] => 20230374599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => GERMLINE BIOMARKERS OF CLINICAL RESPONSE AND BENEFIT TO IMMUNE CHECKPOINT INHIBITOR THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/031257
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18031257
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/031257 | GERMLINE BIOMARKERS OF CLINICAL RESPONSE AND BENEFIT TO IMMUNE CHECKPOINT INHIBITOR THERAPY | Oct 17, 2021 | Pending |
Array
(
[id] => 18921383
[patent_doc_number] => 20240024387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => PROBIOTIC DELIVERY SYSTEMS AND METHODS OF MAKING AND USING
[patent_app_type] => utility
[patent_app_number] => 18/248491
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248491
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248491 | PROBIOTIC DELIVERY SYSTEMS AND METHODS OF MAKING AND USING | Oct 14, 2021 | Pending |
Array
(
[id] => 17505215
[patent_doc_number] => 20220098317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => METHODS FOR TREATING NEPHROTIC SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/498278
[patent_app_country] => US
[patent_app_date] => 2021-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17498278
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/498278 | Methods for treating nephrotic syndrome | Oct 10, 2021 | Issued |
Array
(
[id] => 18911303
[patent_doc_number] => 11874279
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Methods and arrays for target analyte detection and determination of target analyte concentration in solution
[patent_app_type] => utility
[patent_app_number] => 17/496926
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 24
[patent_no_of_words] => 13757
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17496926
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/496926 | Methods and arrays for target analyte detection and determination of target analyte concentration in solution | Oct 7, 2021 | Issued |
Array
(
[id] => 18877492
[patent_doc_number] => 20240000861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => THERAPEUTIC BACTERIAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/247383
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247383
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/247383 | THERAPEUTIC BACTERIAL COMPOSITION | Oct 3, 2021 | Pending |
Array
(
[id] => 17503951
[patent_doc_number] => 20220097053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => FLUID HANDLING DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/481606
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17481606
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/481606 | FLUID HANDLING DEVICE | Sep 21, 2021 | Abandoned |
Array
(
[id] => 17297924
[patent_doc_number] => 20210393763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => NOVEL PNEUMOCOCCAL VACCINE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/460658
[patent_app_country] => US
[patent_app_date] => 2021-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17460658
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/460658 | NOVEL PNEUMOCOCCAL VACCINE FORMULATIONS | Aug 29, 2021 | Abandoned |
Array
(
[id] => 17297923
[patent_doc_number] => 20210393762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => BACTERIAL VACCINE COMPONENTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/410908
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410908
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/410908 | BACTERIAL VACCINE COMPONENTS AND USES THEREOF | Aug 23, 2021 | Abandoned |
Array
(
[id] => 19209541
[patent_doc_number] => 11998576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Direct-fed microbials
[patent_app_type] => utility
[patent_app_number] => 17/403284
[patent_app_country] => US
[patent_app_date] => 2021-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16374
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17403284
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/403284 | Direct-fed microbials | Aug 15, 2021 | Issued |
Array
(
[id] => 17385595
[patent_doc_number] => 20220033447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => ENGINEERED BOTULINUM NEUROTOXIN
[patent_app_type] => utility
[patent_app_number] => 17/400441
[patent_app_country] => US
[patent_app_date] => 2021-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23039
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17400441
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/400441 | ENGINEERED BOTULINUM NEUROTOXIN | Aug 11, 2021 | Abandoned |
Array
(
[id] => 18964192
[patent_doc_number] => 11897943
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
[patent_app_type] => utility
[patent_app_number] => 17/397915
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 21
[patent_no_of_words] => 23710
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17397915
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/397915 | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection | Aug 8, 2021 | Issued |
Array
(
[id] => 18921382
[patent_doc_number] => 20240024386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => MICROBIOME MEDIATED INDUCTION OF IMMUNE TOLERANCE AND RESOLUTION OF INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 18/018178
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018178
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018178 | MICROBIOME MEDIATED INDUCTION OF IMMUNE TOLERANCE AND RESOLUTION OF INFLAMMATION | Jul 26, 2021 | Pending |
Array
(
[id] => 18628599
[patent_doc_number] => 20230287473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => BACTERIAL SPORE GERMINATION ASSAY OF MICROBIOTA DISRUPTION
[patent_app_type] => utility
[patent_app_number] => 18/006236
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006236
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/006236 | BACTERIAL SPORE GERMINATION ASSAY OF MICROBIOTA DISRUPTION | Jul 20, 2021 | Pending |
Array
(
[id] => 18144718
[patent_doc_number] => 20230018570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => CHEMICAL AMPLIFICATION BASED ON FLUID PARTITIONING
[patent_app_type] => utility
[patent_app_number] => 17/305807
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305807
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305807 | CHEMICAL AMPLIFICATION BASED ON FLUID PARTITIONING | Jul 13, 2021 | Abandoned |